The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo

Single-component adjuvant is prone to eliciting a specific type of Th1 or Th2 response. So, the development of combinatorial adjuvants inducing a robust mixed Th1/Th2 response is a promising vaccination strategy against cancer. Here, we describe a novel combination of aluminum salts (alum), CpG olig...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Tian, Yaomei, Li, Meng, Yu, Chaoheng, Zhang, Rui, Zhang, Xueyan, Huang, Rong, Lu, Lian, Yuan, Fengjiao, Fan, Yingzi, Zhou, Bailing, Men, Ke, Xu, Heng, Yang, Li
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542240/
https://ncbi.nlm.nih.gov/pubmed/28515346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17504
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky